Cell Therapeutics to Report Second Quarter Financial Results after Market on July 31, 2013

 Cell Therapeutics to Report Second Quarter Financial Results after Market on
                                July 31, 2013

- Conference call and webcast at 4:30 p.m. Eastern Time -

PR Newswire

SEATTLE, July 24, 2013

SEATTLE, July 24, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ
and MTA: CTIC) announced today that it will report its second quarter
financial results on Wednesday, July 31, 2013, after the close of the U.S.
financial markets. Following the announcement, members of the management team
will host a webcast conference call to discuss the results and provide a
general corporate update at 4:30 p.m. EDT (1:30 p.m. PDT). Access to the event
can be obtained as follows:

Wednesday, July 31, 2013
1:30 p.m. PDT/4:30 p.m. EDT/10:30 p.m. CET
1-877-941-6010 (domestic)
+1 480-629-9643 (international)

To access the live audio webcast or the subsequent archived recording, visit
www.celltherapeutics.com. Webcast and telephone replays of the conference call
will be available at approximately two hours after completion of the call.
Callers can access the replay by dialing 1-800-406-7325 (domestic) or +1
303-590-3030 (international). The access code for the replay is 4632014. The
telephone replay will be available until Wednesday, August 7, 2013.

About Cell Therapeutics, Inc.

Cell Therapeutics (NASDAQ and MTA: CTIC) is a biopharmaceutical company
committed to the development and commercialization of an integrated portfolio
of oncology products aimed at making cancer more treatable. CTI is
headquartered in Seattle, WA. For additional information and to sign up for
email alerts and get RSS feeds, please visit www.CellTherapeutics.com.


Monique Greer
+1 206-272-4343

Ed Bell
+1 206.282.7100

In Europe

CTI Life Sciences Limited, Milan Branch
Laura Villa
T: +39 02 89659706
E: lvilla@cti-lifesciences.com

SOURCE Cell Therapeutics, Inc.

Website: http://www.celltherapeutics.com
Press spacebar to pause and continue. Press esc to stop.